Buy Tirzepatide pen – Research Peptide | PEPTEX
Lyophilised lipidated 39-amino-acid dual GLP-1/GIP receptor peptide (CAS 2023788-19-2; MW 4813.53 Da). Purity ≥98% by HPLC. Supplied as a sterile lyophilised powder in a sealed borosilicate glass vial with a sterile diluent vial. Intended for laboratory and research purposes only. Store at −20°C, keep away from light and moisture.
Price: EUR | Brand: PEPTEX | In Stock | EU-wide delivery, 3-5 business days
Rating: 4.9/5 (891 reviews)
Customer Reviews
Malgorzata — ★★★★★
My doctor was surprised I was using an injectable for weight management (she expected oral medication). When I showed her the pen format she said it looked more professional and controlled than she expected. Peptex quality speaks for itself.
linn.s — ★★★★★
Recommended the pen to three friends who were interested in tirzepatide but intimidated by vials. All three are now ordering regularly. The pen format lowered the entry barrier dramatically. Quality is peptex standard (excellent).
Ragnar — ★★★★★
The pen format makes titration simpler for beginners. The dial shows exactly how much you're injecting. No concentration calculations, no unit conversions. Peptex engineered this well.
andrea_fit — ★★★★★
The pen format eliminated every barrier I had with tirzepatide. No reconstitution, no dose calculations, no syringe technique to learn. Dial the dose, inject, done. Lost 8kg in three months. Peptex pen quality is excellent.
george_93 — ★★★★★
travel with the tirzepatide pen monthly. flies through airport security without questions (looks like an insulin pen). keeps cold in my travel cooler for 8+ hours. peptex made my weight loss protocol completely portable
Available Sizes
- 30mg — 209 EUR
- 60mg — 349 EUR
Research References
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — NEJM / PubMed (2022)
- Tirzepatide versus Semaglutide Once Weekly in Type 2 Diabetes (SURPASS-2) — NEJM / PubMed (2021)
- Efficacy and safety of tirzepatide monotherapy in type 2 diabetes (SURPASS-1) — Lancet / PubMed (2021)
💬 Комментарии